94055-76-2
Chemical Structure
Suplatast (Tosilate)
Synonym(s): IPD 1151T
- CAS No.: 94055-76-2
- Formula:C23H33NO7S2
- Molecular Weight:499.64
IUPAC Name: (3-((4-(3-ethoxy-2-hydroxypropoxy)phenyl)amino)-3-oxopropyl)dimethylsulfonium 4-methylbenzenesulfonate
InChIKey: RYVJQEZJUFRANT-UHFFFAOYSA-N
SMILES: C[S+](C)CCC(NC1=CC=C(C=C1)OCC(COCC)O)=O.CC2=CC=C(C=C2)S(=O)([O-])=O
Biological Activity: Suplatast Tosilate (IPD 1151T) is an orally active Th2 cytokine inhibitor which can inhibit both IL-4 and IL-5 production from Th2 cells and suppress IgE synthesis. Suplatast Tosilate is an anti-allergic agent. Suplatast Tosilate has antiasthmatic, anti-inflammatory and antifibrotic activity[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Suplatast (Tosilate) | 99.67% | Suplatast Tosilate (IPD 1151T) is an orally active Th2 cytokine inhibitor which can inhibit both IL-4 and IL-5 production from Th2 cells and suppress IgE synthesis. Suplatast Tosilate is an anti-allergic agent. Suplatast Tosilate has antiasthmatic, anti-inflammatory and antifibrotic activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.56
HY-119893Diamfenetide -
Similarity Score 0.56
HY-121843Ronactolol -
Similarity Score 0.55
HY-Z19621Acebutolol impurity 4 -
Similarity Score 0.55
HY-W1074664-((4-((4-Aminophenyl)sulfonyl)phenyl)amino)-4-oxobutanoic acid -
Similarity Score 0.54
HY-Z7837Atenolol impurity 9 -
Similarity Score 0.54
HY-W010948Diethylene glycol bis(p-toluenesulfonate) -
Similarity Score 0.54
HY-W013731Triethylene glycol bis(p-toluenesulfonate) -
Similarity Score 0.54
HY-101812Terbufibrol -
Similarity Score 0.53
HY-175341Rac1-IN-5 -
Explore the MedChemAI to find more analogs
References
- [1]. Yanagihara Y, et, al. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (2). Regulation of human IgE response. Jpn J Pharmacol. 1993 Jan;61(1):31-9. [Content Brief]
- [2]. Zhao GD, et, al. Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: inhibition of eosinophilic inflammation and bronchial hyperresponsiveness. Int Arch Allergy Immunol. 2000 Feb;121(2):116-22. [Content Brief]
- [3]. Kurokawa M, et, al. Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo. Mediators Inflamm. 2001 Dec;10(6):333-7. [Content Brief]
- [4]. Furonaka M, Hattori N, Tanimoto T, Senoo T, Ishikawa N, Fujitaka K, Haruta Y, Yokoyama A, Kohno N. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther. 2009 Jan;328(1):55-61. [Content Brief]
